These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9862172)

  • 1. Effect of probucol on serum lipids, atherosclerosis and toxicology in fat-fed LDL receptor deficient mice.
    Benson GM; Schiffelers R; Nicols C; Latcham J; Vidgeon-Hart M; Toseland CD; Suckling KE; Groot PH
    Atherosclerosis; 1998 Dec; 141(2):237-47. PubMed ID: 9862172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of probucol on atherosclerosis of apoE-deficient or LDL receptor-deficient mice.
    Yoshikawa T; Shimano H; Chen Z; Ishibashi S; Yamada N
    Horm Metab Res; 2001 Aug; 33(8):472-9. PubMed ID: 11544561
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probucol inhibits the initiation of atherosclerosis in cholesterol-fed rabbits.
    Niimi M; Keyamura Y; Nozako M; Koyama T; Kohashi M; Yasufuku R; Yoshikawa T; Fan J
    Lipids Health Dis; 2013 Nov; 12():166. PubMed ID: 24188322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiatherogenic effects of cilostazol and probucol alone, and in combination in low density lipoprotein receptor-deficient mice fed with a high fat diet.
    Yoshikawa T; Mitani K; Kotosai K; Nozako M; Miyakoda G; Yabuuchi Y
    Horm Metab Res; 2008 Jul; 40(7):473-8. PubMed ID: 18404599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.
    El-Swefy S; Schaefer EJ; Seman LJ; van Dongen D; Sevanian A; Smith DE; Ordovas JM; El-Sweidy M; Meydani M
    Atherosclerosis; 2000 Apr; 149(2):277-86. PubMed ID: 10729377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probucol selectively increases oxidation of atherogenic lipoproteins in cholesterol-fed mice and in Watanabe heritable hyperlipidemic rabbits.
    Lauridsen ST; Mortensen A
    Atherosclerosis; 1999 Jan; 142(1):169-78. PubMed ID: 9920518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidized fatty acids promote atherosclerosis only in the presence of dietary cholesterol in low-density lipoprotein receptor knockout mice.
    Khan-Merchant N; Penumetcha M; Meilhac O; Parthasarathy S
    J Nutr; 2002 Nov; 132(11):3256-62. PubMed ID: 12421837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary antioxidants inhibit development of fatty streak lesions in the LDL receptor-deficient mouse.
    Crawford RS; Kirk EA; Rosenfeld ME; LeBoeuf RC; Chait A
    Arterioscler Thromb Vasc Biol; 1998 Sep; 18(9):1506-13. PubMed ID: 9743241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous and diet-aggravated hemolysis and its correction by probucol in SR-BI knockout mice with LDL-R deficiency.
    Liao J; Gao M; Wang M; Guo X; Huang W; Liu G
    Biochem Biophys Res Commun; 2015 Jul 17-24; 463(1-2):48-53. PubMed ID: 25983325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of atorvastatin and/or probucol on recovery of atherosclerosis in high-fat-diet-fed apolipoprotein E-deficient mice.
    Guo X; Wang L; Xia X; Wang P; Li X
    Biomed Pharmacother; 2019 Jan; 109():1445-1453. PubMed ID: 30551396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of probucol on LDL oxidation and atherosclerosis in LDL receptor-deficient mice.
    Bird DA; Tangirala RK; Fruebis J; Steinberg D; Witztum JL; Palinski W
    J Lipid Res; 1998 May; 39(5):1079-90. PubMed ID: 9610776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin E combined with selenium inhibits atherosclerosis in hypercholesterolemic rabbits independently of effects on plasma cholesterol concentrations.
    Schwenke DC; Behr SR
    Circ Res; 1998 Aug; 83(4):366-77. PubMed ID: 9721693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paradoxical enhancement of atherosclerosis by probucol treatment in apolipoprotein E-deficient mice.
    Zhang SH; Reddick RL; Avdievich E; Surles LK; Jones RG; Reynolds JB; Quarfordt SH; Maeda N
    J Clin Invest; 1997 Jun; 99(12):2858-66. PubMed ID: 9185508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined treatment of probucol with diltiazem regresses atherosclerosis induced by 196 cholesterol diet in rabbit aorta.
    Kouzuma R; Tasaki H; Komura T; Nakashima Y; Kuroiwa A; Tanimoto A; Koide O
    Artery; 1995; 21(6):337-51. PubMed ID: 8833232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary isoflavones reduce plasma cholesterol and atherosclerosis in C57BL/6 mice but not LDL receptor-deficient mice.
    Kirk EA; Sutherland P; Wang SA; Chait A; LeBoeuf RC
    J Nutr; 1998 Jun; 128(6):954-9. PubMed ID: 9614153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probucol and cilostazol exert a combinatorial anti-atherogenic effect in cholesterol-fed rabbits.
    Chen Y; Zhao S; Huang B; Wang Y; Li Y; Waqar AB; Liu R; Bai L; Fan J; Liu E
    Thromb Res; 2013 Nov; 132(5):565-71. PubMed ID: 24090606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probucol Protects Against Atherosclerosis Through Lipid-lowering and Suppressing Immune Maturation of CD11c+ Dendritic Cells in STZ-induced Diabetic LDLR-/- Mice.
    Zhu H; Jin X; Zhao J; Dong Z; Ma X; Xu F; Huang W; Liu G; Zou Y; Wang K; Hu K; Sun A; Ge J
    J Cardiovasc Pharmacol; 2015 Jun; 65(6):620-7. PubMed ID: 25714599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of aortic cholesterol deposition by dietary linoleic acid in cholesterol-fed mice: an animal model for primary screening of antiatherosclerotic agents.
    Yamaguchi Y; Kitagawa S; Imaizumi N; Kunitomo M; Fujiwara M
    J Pharmacol Toxicol Methods; 1993 Nov; 30(3):169-75. PubMed ID: 8305719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dietary alpha-lipoic acid supplementation inhibits atherosclerotic lesion development in apolipoprotein E-deficient and apolipoprotein E/low-density lipoprotein receptor-deficient mice.
    Zhang WJ; Bird KE; McMillen TS; LeBoeuf RC; Hagen TM; Frei B
    Circulation; 2008 Jan; 117(3):421-8. PubMed ID: 18158360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proatherogenic and antiatherogenic effects of probucol and phytosterols in apolipoprotein E-deficient mice: possible mechanisms of action.
    Moghadasian MH; McManus BM; Godin DV; Rodrigues B; Frohlich JJ
    Circulation; 1999 Apr; 99(13):1733-9. PubMed ID: 10190884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.